ABSTRACT
Every year an estimated 5 to 8 million people die in low- and middle-income countries (LMICs) due to poor-quality care. Although quality improvements in healthcare facilities in LMICs are well-possible with tailored implementation plans, costs are often mentioned as a prohibiting factor. However, if quality improvements increase trust among patients, this might translate into increased visits and higher revenues for providers and enable them to further invest in quality. This paper assesses the potential business case of quality improvements in Sub-Saharan Africa (SSA). It focuses on both the public and private sector since the latter provides at least half of all health services in SSA. The analysis is based on a dataset including multiple assessments of quality and business performance indicators for almost 500 health facilities in Tanzania, Kenya, Ghana, Nigeria, and other SSA-countries. We studied the association between changes in quality assessment scores and subsequent changes in numbers of patient visits and staff as proxies for business growth. We found that quality improvements significantly improved business performance indicators, but only for those facilities that had already reached a certain level of quality to begin with. These findings suggest an S-shaped relationship between quality and business performance, leading to the existence of a ‘low-quality trap’. Substantial financial investments might be needed initially to support facilities at the bottom of the distribution in reaching a basic level of quality, after which further quality investments may start translating into increased revenues, enhancing business performance.
Key messages
Millions of people die every year in low- and middle-income countries (LMICs) due to low quality of care
To reach Universal Health Coverage, drastic quality improvements are essential
Achieving quality of care in LMICs is possible but challenging because it requires substantial financial investments, specialized skills and sufficient human resources
We found there is a business case for quality investments in SSA, as quality improvements are associated with a significant increase in the number of patient visits and staff over time, indicative of greater revenue streams and financial capacity
Targeted financing programmes together with technical assistance to healthcare facilities are critical to drive quality investments, especially for facilities at the beginning of their quality improvement journeys
Competing Interest Statement
Some authors are current employees of PharmAccess Foundation, an institution discussed in this article. These affiliations are explicitly listed in the article.
Funding Statement
This work was supported by the Health Insurance Fund of the Minister of Foreign Affairs of The Netherlands.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵† These authors are joint last authors
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
